Press Releases
20 August 2019
OraSure Technologies, Inc., a leader in point-of-care diagnostic tests and specimen collection devices, today announced the sale of its cryosurgical systems business to CryoConcepts, LP for an aggr
Read more...17 August 2019
The U.S. Food and Drug Administration today approved the first spinal tether device intended to be used in children and adolescents to correct the most common form of scoliosis, called idiopathic s
Read more...16 August 2019
Concept Medical Inc. (CMI) has been awarded a Breakthrough Device Designation by the US Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), a drug- coated
Read more...14 August 2019
CityMD, the leading urgent care provider in the New York metro area, and Summit Medical Group, one of the nation's premier independent multispecialty medical practices, today announced the comp
Read more...13 August 2019
Health in Motion Network secured a network agreement with Gateway2Better Network™ and access to 3,500 Urgent Care Centers nationally. By partnering with the Urgent Care Association
Read more...9 August 2019
Masimo today announced that continuous noninvasive hemoglobin monitoring SpHb ® for neonatal and infant patients (<3 kg) CE mark . With this approval, patients of all ages in the CE marked c
Read more...Perfuze, a medical device company developing next-generation catheter-based technology to treat acute ischemic stroke, has been granted Breakthrough Device Designation by the U.S. FDA for its Milli
Read more...7 August 2019
The privately-owned company, MT.DERM GmbH, Berlin, Germany, a manufacturer of medical microneedling, micropigmentation and tattoo equipment is excited to announce further expansion into the US mark
Read more...6 August 2019
RenalSense announced that it has obtained CE Mark approval for its Clarity RMS™ system for real-time monitoring of urine flow in the critical care and peri-operative setting. The CE Mark appr
Read more...5 August 2019
Transgene, a biotech company designing and developing virus-based immunotherapies for the treatment of solid tumors, today announces that the independent Data Monitoring Committee (“IDMC&rdqu
Read more...
